Oct. 13, 2020 |
|
Mar. 01, 2023 |
|
jRCTb032200148 |
Multicenter clinical study on the efficacy and safety with extensive and repeated injections of cultured (human) autologous hair follicle dermal sheath cup cells on male and female pattern hair loss |
|
Multicenter clinical study on the efficacy and safety with extensive and repeated injections of cultured (human) autologous hair follicle dermal sheath cup cells on male and female pattern hair loss |
|
Kengo Yamamoto |
Harada Kazutoshi |
||
Tokyo Medical University Hospital |
||
6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo |
||
+81-3-3342-6111 |
||
kharada@tokyo-med.ac.jp |
||
Harada Kazutoshi |
||
Tokyo Medical University Hospital |
||
6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo |
||
+81-3-3342-6111 |
||
kharada@tokyo-med.ac.jp |
36 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
treatment purpose |
||
1. Male or female of 20 year old or more with in good health having pattern hair loss involving the vertex area of the scalp. |
||
1. Use of any product (medication or otherwise) which interferes with the hair growth cycle. |
||
20age old over | ||
No limit | ||
Both |
||
male and female pattern hair loss |
||
1. blood sampling from the subjects. |
||
Based on the global photo assessment, photos will have to be taken at 12 months medications, and will be employed as a primary endpoint. These photos taken following injections of S-DSC will have to be analyzed. |
||
Quantitative analysis by Phototrichogram (hair density etc.) |
Oct. 13, 2020 | |
Dec. 04, 2020 | |
Not Recruiting |
SHISEIDO CO., LTD. | |
Applicable |
Tokyo Medical University Certified Special Committee for Regenerative Medicine | |
6-1-1 Shinjuku, Shinjuku-ku, Tokyo | |
+81-3-5323-2027 |
|
regn_irb@tokyo-med.ac.jp | |
Approval | |
July. 03, 2020 |